Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver

Annals of Surgical Oncology

Volumn 18, Issue 7, 2011, Pages 1955-1963

  Li, Tao ^a   Fan, Jia ^b   Qin, Lun Xiu ^b   Zhou, Jian ^b   Sun, Hui Chuan ^b   Qiu, Shuang Jian ^b   Ye, Qing Hai ^b   Wang, Lu ^b   Tang, Zhao You ^b  

^a SHANDONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PRIMARY CLEAR CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 80051544107     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1540-z     Document Type: Article

References (44)

1. Gish RG. Hepatocellular carcinoma: overcoming challenges in disease management. Clin Gastroenterol Hepatol. 2006; 4:252-61. (Pubitemid 43343879)
2. Chedid A, Ryan LM, Dayal Y, Wolf BC, Falkson G. Morphology and other prognostic factors of hepatocellular carcinoma. Arch Pathol Lab Med. 1999;123:524-8. (Pubitemid 29255031)
3. Ross JS, Kurian S. Clear cell hepatocellular carcinoma: sudden death from severe hypoglycemia. Am J Gastroenterol. 1985;80: 188-94. (Pubitemid 15139234)
4. Liu Z, Ma W, Li H, Li Q. Clinicopathological and prognostic features of primary clear cell carcinoma of the liver. Hepatol Res. 2008;38:291-9. (Pubitemid 351193958)
5. Emile JF, Lemoine A, Azoulay D, Debuire B, Bismuth H, Reynès M.Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma. Histopathology. 2001;38:225-31. (Pubitemid 32862732)
6. Yang SH, Watanabe J, Nakashima O, Kojiro M. Clinicopathologic study on clear cell hepatocellular carcinoma. Pathol Int. 1996;46:503-9. (Pubitemid 26299468)
7. Wu PC, Lai CL, Lam KC, Lok AS, Lin HJ. Clear cell carcinoma of liver. An ultrastructural study. Cancer. 1983;52:504-7. (Pubitemid 13073480)
8. Buchanan TF Jr, Huvos AG. Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients. Am J Clin Pathol. 1974; 61:529-39.
9. Orsatti G, Arnold MM, Paronetto F. DNA image cytometric analysis of primary clear cell carcinoma of the liver. Arch Pathol Lab Med. 1994;118:1226-9. (Pubitemid 24373101)
10. Lai CL, Wu PC, Lam KC, Todd D. Histologic prognostic indicators in hepatocellular carcinoma. Cancer. 1979;44:1677-83. (Pubitemid 10140394)
11. McDermott WV, Cady B, Georgi B, Steele G Jr, Khettry U. Primary cancer of the liver. Evaluation, treatment, and prognosis. Arch Surg. 1989;124:552-4.
12. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol. 2000; 33:282-9. (Pubitemid 30485232)
13. Edmondson HA. Tumours of the liver and intrahepatic bile ducts. In: Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology, 1958;49.
14. Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol. 2007;14:2319-29. (Pubitemid 47174899)
15. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89: 500-7. (Pubitemid 30640096)
16. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: longterm results of treatment and prognostic factors. Ann Surg. 1999;229:216-22. (Pubitemid 30191795)
17. Yang W, Chen MH, Yin SS, Yan K, Gao W, Wang YB, et al. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence. Am J Roentgenol. 2006;186:S275-83. (Pubitemid 46114731)
18. Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H, et al. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. Surg Oncol. 2009;18:25-30.
19. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology. 1992;16:1367-71.
20. Toyosaka A, Okamoto E, Mitsunobu M, Oriyama T, Nakao N, Miura K. Pathologic and radiographic studies of intrahepatic metastasis in hepatocellular carcinoma; the role of efferent vessels. HPB Surg. 1996;10:97-103.
21. Matsumata T, Kanematsu T, Takenaka K, Yoshida Y, Nishizaki T, Sugimachi K. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology. 1989;9: 457-60. (Pubitemid 19074982)
22. Nagao T, Inoue S, Yoshimi F, Sodeyama M, Omori Y, Mizuta T, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg. 1990;211:28-33. (Pubitemid 20027879)
23. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996;83:1219-22. (Pubitemid 26290448)
24. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229-35. (Pubitemid 43185442)
25. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24. (Pubitemid 30456545)
26. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995; 108:768-75.
27. Tarao K, Rino Y, Takemiya S, Tamai S, Miyakawa K, Takakura H, et al. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma. Intervirology. 2000;43:20-6. (Pubitemid 30206806)
28. Tarao K, Takemiya S, Tamai S, Sugimasa Y, Ohkawa S, Akaike M, et al. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer. 1997;79:688-94. (Pubitemid 27076334)
29. Moriyama M, Matsumura H, Aoki H, Shimizu T, Yamagami H, Shioda A, et al. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy. Liver Int. 2005;25:85-90. (Pubitemid 40298249)
30. Tarao K, Hoshino H, Shimizu A, Ohkawa S, Nakamura Y, Harada M, et al. Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma. Jpn J Cancer Res. 1994;85:1040-4. (Pubitemid 24325026)
31. Taketomi A, Takenaka K, Matsumata T, Shimada M, Higashi H, Shirabe K, et al. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma before and after hepatic resection. Hepatogastroenterology. 1997;44:477-83. (Pubitemid 27171061)
32. Arase Y, Chayama K, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, et al. Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C. Hepatol Res. 2001;21: 55-66. (Pubitemid 32725375)
33. Sun HC, Tang ZY, Wang L, Qin LX, Ma ZC, Ye QH, et al. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol. 2006;132:458-65.
34. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Yamazaki O, et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med. 2001;134:963-7. (Pubitemid 32466235)
35. Lyman GH, Lyman S, Balducci L, Kuderer N, Reintgen D, Cox C, et al. Age and the risk of breast cancer recurrence. Cancer Control. 1996;3:421-7. (Pubitemid 26381166)
36. Yamazaki H, Inoue T, Koizumi M, Yoshida K, Kagawa K, Shiomi H, et al. Age as a prognostic factor for late local recurrence of early tongue cancer treated with brachytherapy. Anticancer Res. 1997;17:4709-12. (Pubitemid 28081769)
37. Shimada K, Sakamoto Y, Esaki M, Kosuge T, Morizane C, Ikeda M, et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol. 2007;14:2337-47. (Pubitemid 47174918)
38. Chan KM, Lee WC, Hung CF, Yu MC, Jan YY, Chen MF. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection. Chang Gung Med J. 2005;28:543-50.
39. Tanaka K, Shimada H, Togo S, Takahashi T, Endo I, Sekido H, et al. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Hepatogastroenterology. 1999;46:1083-8. (Pubitemid 29224797)
40. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med. 1996,334:1561-7. (Pubitemid 26177483)
41. Muto Y, Moriwaki H, Saito A. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med. 1999;340:1046-7. (Pubitemid 29157643)
42. Biselli M, Andreone P, Gramenzi A, Trevisani F, Cursaro C, Rossi C, et al. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study. Clin Gastroenterol Hepatol. 2005;3:918-25. (Pubitemid 41219296)
43. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356:125-34. (Pubitemid 46089673)
44. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378-90.